Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach

Since 1906, when Dr. Alois Alzheimer first described in a patient “a peculiar severe disease process of the cerebral cortex”, people suffering from this pathology have been waiting for a breakthrough therapy. Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative brain disorder a...

Descripción completa

Detalles Bibliográficos
Autores principales: Morató, Xavier, Pytel, Vanesa, Jofresa, Sara, Ruiz, Agustín, Boada, Mercè
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409252/
https://www.ncbi.nlm.nih.gov/pubmed/36012569
http://dx.doi.org/10.3390/ijms23169305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409252/
https://www.ncbi.nlm.nih.gov/pubmed/36012569
http://dx.doi.org/10.3390/ijms23169305

Ejemplares similares